Lv1
40 积分 2023-06-12 加入
PL02.09 Aumolertinib plus Chemotherapy for NSCLC with EGFR and Concomitant Tumor Suppressor Genes (ACROSS 2): Phase III study
1天前
求助中
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
2天前
已完结
Four novel RECQL4 mutations in four Chinese patients with Rothmund-Thomson syndrome and analysis of RECQL4 mRNA expression level in one typical patient
7天前
已完结
A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC): Genomic sequencing and updated efficacy results
1个月前
已完结
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
1个月前
已完结
Gene of the month:PIK3CA
1个月前
已完结
PIK3CA in cancer: The past 30 years
1个月前
已完结
Genotypes and phenotypes heterogeneity in PIK3CA-related overgrowth spectrum and overlapping conditions: 150 novel patients and systematic review of 1007 patients with PIK3CA pathogenetic variants
1个月前
已完结
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
1个月前
已完结
Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network
1个月前
已完结
皖公网安备34019202002308
